Number | 1578 | 1709 | 3734 |
Age (years)* | | | |
19–49 | 21.8% | 18.0% | 15.8% |
50–69 | 67.8% | 63.5% | 55.7% |
⩾70 | 10.4% | 18.5% | 28.6% |
Sex* | | | |
Men | 73.3% | 71.3% | 65.6% |
Women | 26.7% | 28.7% | 34.4% |
Indication* | | | |
Acute | 5.8% | 24.3% | 44.0% |
Elective | 94.2% | 75.7% | 56.0% |
Angiographic status* | | | |
No significant stenoses | 14.6% | 20.2% | 27.1% |
1 VD | 16.4% | 26.1% | 27.5% |
2 VD | 13.1% | 22.4% | 17.5% |
3 VD | 24.4% | 26.8% | 20.0% |
PLM stenosis | 4.3% | 4.5% | 6.3% |
Missing data | 27.3% | 0.0% | 1.5% |
Charlson co-morbidity index* | | | |
0 | 34.1% | 35.7% | 35.9% |
1–2 | 58.9% | 54.4% | 51.3% |
>2 | 6.9% | 9.9% | 12.7% |
Revascularisation at baseline or within one year of follow up* | 47.5% | 54.7% | 58.8% |
Time to revascularisation (days)*† | 91 (0–365) | 33 (0–365) | 0 (0–365) |
Total follow up (years) | 4357 | 4737 | 10408 |
Number of deaths during follow up | 188 | 185 | 419 |